Table 2.
Variables | Decrease in pre-pandemic sexual functioning | Decrease in sexual functioning during the pandemic | Decrease in sexual functioning due to both Diabetes and Covid-19 | ||||||
---|---|---|---|---|---|---|---|---|---|
Decrease | No Change | Test Value | Decrease | No Change | Test Value | Decrease | No Change | Test Value | |
Age | |||||||||
Mean ± SD | 56.36 ± 11.22 | 56.18 ± 12.23 | bp < .05** | 56.45 ± 13.02 | 56.06 ± 13.58 | bp < .05** | 56.66 ± 12.96 | 57.05 ± 13.98 | bp < .05** |
Gender % | |||||||||
Female | 74 (54.8) | 16 (59.3) | bp < .05** | 66 (58.4) | 24 (49) | bp < .05** | 63 (57.8) | 12 (48) | bp < .05** |
Male | 61 (45.2) | 11 (40.7) | 47 (41.6) | 25 (51) | 46 (42.2) | 13(52) | |||
Duration of Diabetes | |||||||||
Mean ± SD | 9.11 ± 4.85 | 8.98 ± 4.56 | bp < .05** | 9.56 ± 5.58 | 7.91 ± 3.45 | bp < .05** | 9.81 ± 2.58 | 7.02 ± 3.15 | bp < .05** |
HbA1c (%) | |||||||||
Mean ± SD | 9.48 ± 2.31 | 9.39 ± 2.03 | bp < .05** | 9.51 ± 2.31 | 9.36 ± 2.17 | bp < .05** | 9.51 ± 2.35 | 9.35 ± 2.11 | bp < .05** |
bMann–Whitney U Test **p < 0.05